cholestyramine resin has been researched along with metoclopramide in 6 studies
Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (metoclopramide) | Trials (metoclopramide) | Recent Studies (post-2010) (metoclopramide) |
---|---|---|---|---|---|
2,669 | 342 | 190 | 5,044 | 1,216 | 623 |
Protein | Taxonomy | cholestyramine resin (IC50) | metoclopramide (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.383 | |
Myeloperoxidase | Homo sapiens (human) | 0.35 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 2.721 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.8 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.127 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 7.8 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 3.675 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.383 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 7.8 | |
5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 7.8 | |
5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 7.8 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.2 | |
5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.88 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.63 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.8 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.6237 | |
5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.88 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Langman, MJ | 1 |
Lux, G | 1 |
Cooperman, AM | 1 |
Chrubasik, S; Schusziarra, V | 1 |
Farthmann, EH; Fritsch, WP | 1 |
Teilum, D | 1 |
3 review(s) available for cholestyramine resin and metoclopramide
Article | Year |
---|---|
Drugs in the treatment of gastric and duodenal ulcer.
Topics: Amylopectin; Antacids; Bismuth; Carbenoxolone; Cholestyramine Resin; Duodenal Ulcer; Estrogens; Fatty Acids, Unsaturated; Glycyrrhiza; Histamine H2 Antagonists; Humans; Imidazoles; Metoclopramide; Parasympatholytics; Plants, Medicinal; Prostaglandins, Synthetic; Recurrence; Stomach Ulcer; Zinc | 1977 |
[Current status of peptic ulcer therapy].
Topics: Antacids; Carbenoxolone; Cholestyramine Resin; Humans; Metoclopramide; Parasympatholytics; Peptic Ulcer; Prostaglandins | 1978 |
Postoperative alkaline reflux gastritis.
Topics: Cholestyramine Resin; Gastritis; Gastroenterostomy; Humans; Metoclopramide; Postgastrectomy Syndromes | 1976 |
3 other study(ies) available for cholestyramine resin and metoclopramide
Article | Year |
---|---|
[Gastric ulcer caused by digestive juice reflex].
Topics: Bile Acids and Salts; Cholestyramine Resin; Duodenum; Gastric Juice; Gastrins; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Intestinal Secretions; Metoclopramide; Stomach Ulcer | 1981 |
[Conditions after total gastrectomy].
Topics: Adenocarcinoma; Anemia, Hypochromic; Antacids; Cholestyramine Resin; Dumping Syndrome; Esophagitis, Peptic; Feeding Behavior; Gastrectomy; Humans; Metoclopramide; Nutritional Physiological Phenomena; Pain; Stomach; Stomach Neoplasms | 1982 |
Reflux esophagitis.
Topics: Antacids; Biopsy; Cholestyramine Resin; Cimetidine; Endoscopy; Esophagitis, Peptic; Esophagogastric Junction; Fiber Optic Technology; Gastric Acid; Gastric Emptying; Humans; Hydrogen-Ion Concentration; Manometry; Metoclopramide; Pressure | 1982 |